Archive Newsletter

41. 11.20.24 -- Regulatory Considerations For mRNA Platforms 11/20/2024
    11/20/24 Advancing RNA Newsletter
42. 11.13.24 -- Strategies To Address FDA CMC Trends For mRNA Therapies 11/13/2024
    11/13/24 Advancing RNA Newsletter
43. 11.06.24 -- Mastering mRNA Manufacturing: A Focus On Raw Materials & Supply Assurance 11/6/2024
    11/06/24 Advancing RNA Newsletter
44. 10.31.24 -- Navigate Regulatory Landscapes In Your mRNA Drug Development 10/31/2024

    10/31/24 Advancing RNA Newsletter

45. 10.31.24 -- Key Considerations For Aseptic Filling 10/31/2024

    10/31/24 Advancing RNA Newsletter

46. 10.30.24 -- A "Flight Plan" For Achieving These 3 mRNA Development Milestones 10/30/2024
    10/30/24 Advancing RNA Newsletter
47. 10.28.24 -- Nanoparticle Enabled Formulation And Drug Delivery Solutions 10/28/2024
    10/28/24 Advancing RNA Newsletter
48. 10.24.24 -- Are We Really Living In An mRNA Regulatory "Desert"? 10/24/2024
    10/24/24 Advancing RNA Newsletter
49. 10.17.24 -- Resources For Trouble-Free Validation 10/17/2024

    10/17/24 Advancing RNA Newsletter

50. 10.16.24 -- Shifting Scales: Considerations For Small-Scale mRNA Production 10/16/2024
    10/16/24 Advancing RNA Newsletter